Concepedia
Statistics
Publications
5
Citations
147
H-Index
Active since
2018
Affiliations
Hôpital Ambroise-Paré(Current)
Université de Versailles Saint-Quentin-en-Yvelines
Assistance Publique – Hôpitaux de Paris
Université Paris-Saclay
Pitié-Salpêtrière Hospital
Magali Fort is an author at Hôpital Ambroise-Paré specializing in oncology, cancer therapeutics, and immunotherapy.
Top concepts
MedicineOncologyImmunotherapyCancer TherapyHealthRadiologyImmunologyPharmacologyRadiotherapyMolecular Oncology
Publications per year
2018–2021
Efficacy of combined hypo-fractionated radiotherapy and anti-PD-1 monotherapy in difficult-to-treat advanced melanoma patients
Anissa Roger, A. Finet, B. Boru et al. · OncoImmunology · 2018 · 67 citations · Full text
Impact of prior treatment with immune checkpoint inhibitors on dacarbazine efficacy in metastatic melanoma
Sarah Bouchereau, L. Chaplain, Magali Fort et al. · British Journal of Cancer · 2021 · 27 citations · Full text
Dacarbazine Efficacy, Medicine, Immune Checkpoint Inhibitors +9
Efficacy of late concurrent hypofractionated radiotherapy in advanced melanoma patients failing anti‐PD‐1 monotherapy
Elisa Funck‐Brentano, B. Baghad, Magali Fort et al. · International Journal of Cancer · 2020 · 23 citations · Full text
Pembrolizumab and concurrent hypo-fractionated radiotherapy for advanced non-resectable cutaneous squamous cell carcinoma
Justine Lavaud, Astrid Blom, Christine Longvert et al. · European Journal of Dermatology · 2019 · 20 citations · Full text
Efficacy of hypofractionated radiotherapy (Rx) in melanoma patients who failed anti-PD-1 monotherapy: Assessing the abscopal effect.
Philippe Saïag, B. Baghad, Magali Fort et al. · Journal of Clinical Oncology · 2019 · 10 citations
Anti-pd-1 Monotherapy, Radiation Medicine, Abscopal Effect +14
1–5 of 5